Bristol-Myers Squibb to Present at J.P. Morgan Healthcare Conference

NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) will present at the J.P. Morgan Healthcare Conference on Tuesday, January 9, 2018, in San Francisco. Giovanni Caforio, chairman and chief executive officer, will make a formal presentation about the company at 10 a.m. PST (1 p.m. EST).

Investors and the general public are invited to listen to a live webcast of the presentation at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the presentation will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

View source version on businesswire.com: http://www.businesswire.com/news/home/20180103005125/en/

Bristol-Myers Squibb
Media:
Ken Dominski, 609-252-5251
[email protected]
or
Investors:
John Elicker, 609-252-4611
[email protected]
or
Tim Power, 609-252-7509
[email protected]
or
Bill Szablewski, 609-252-5894
[email protected]

Source: Bristol-Myers Squibb

You May Also Be Interested In

• A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
• Creator Network Doomers Reaches $10M Run Rate With Twenty Launch Slots Monthly
• SWE90 Offers Fiduciary Advisory and Brokerage Services in California